Gaois

Similar terms:

This is a static copy of data that is exported from IATE on an occasional basis. It should not be assumed that information provided about an entry here will always correspond to the current version of the entry in IATE. That current version can be checked by clicking on the link on the upper right hand side of each entry. More information »

10 results

  1. SOCIAL QUESTIONS|social affairs|social problem · SOCIAL QUESTIONS|health|pharmaceutical industry|pharmaceutical product|psychotropic substance
    ópóideach Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Definition téarma cineálach a úsáidtear d’alcalóidigh ón bpoipín óipiam, ach úsáidtear é chomh maith do tháirgí óipiam-díorthaithe, leathshintéiseach agus sintéiseach de réir ghnás an EMCDDA Reference an Lárionad Faireacháin Eorpach um Dhrugaí agus um Andúil i nDrugaí (EMCDDA), url: EMCDDA.europa.eu [16/10/2013]
    Opioid
    de
    Definition Sammelbegriff für die Alkaloide des Schlafmohns; der Begriff kann jedoch auch aus Opium gewonnene, halbsynthetische und synthetische Produkte umfassen, die von der EBDD überwacht werden. Reference European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), url:EMCDDA.europa.eu [14.12.2010]
    opioid
    en
    Definition generic term applied to alkaloids from the opium poppy, but can also cover opium-derived, semisynthetic and synthetic products in EMCDDA usage. Reference European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), url:EMCDDA.europa.eu [14.12.2010]
    opioïdes
    fr
    Definition terme générique appliqué aux alcaloïdes provenant du pavot mais pouvant également couvrir, pour l’OEDT, des produits semi-synthétiques ou synthétiques dérivés du pavot. Reference Observatoire européen des drogues et des toxicomanies (OEDT), url:EMCDDA.europa.eu [23.02.2011]
  2. SOCIAL QUESTIONS|health|pharmaceutical industry
    anailgéiseach ópóideach Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Opioid | Opioid-Analgetikum | opioides Analgetikum | Narkoanalgetikum
    de
    Definition natürliche oder synthetische Substanz, die morphinartige Eigenschaften aufweist und an Opioidrezeptoren wirksam ist Reference "Wikipedia, s. v. ""Opioide"", http://de.wikipedia.org/wiki/Opioide (4.9.2013)"
    opioid analgesic drug | opioid analgesic | opioid drug | opioid | narcotic analgesic drug | narcotic analgesic | narcotic agent | narcotic
    en
    Definition "analgesic [ IATE:1364708 ] used to alleviate moderate to severe pain and which is either a natural or semi-synthetic opiate (i.e. alkaloids contained in the resin of the opium poppy or derived from them), or a substance produced naturally in the body or synthetic drug that binds to opioid receptors [ IATE:1150092 ] producing agonist [ IATE:202497 ]" Reference "COM-EN, based on:Erica Y. Ramirez. Opioid Analgesics http://faculty.smu.edu/jbuynak/OpioidAnalgesics_EricaRamirez.ppt [16.5.2012]"
    Comment Natural opiates: morphine, codeine and thebaineSemi-synthetic Opiates: hydromorphone, oxycodone and diacetylmorphine (heroin)Fully synthetic opioids: Fentanyl, methadone and tramadolEndogenous opioid peptides: endorphins, enkephalins, dynorphins and endomorphins.
    analgésique narcotique | narcotique analgésique | analgésique opioïde | opioïde
    fr
    Definition analgésique naturel ou fabriqué (synthétique) utilisé pour soulager les douleurs sévères et modérées Reference "COM-FR, d'après:Santé Canada, Accueil > Vie saine > Votre santé et vous > Aspect médical, Questions fréquentes sur les analgésique opioïdes, http://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/opioid-faq-opioides-fra.php [13.4.2015]"
  3. SOCIAL QUESTIONS|health|pharmaceutical industry
    gabhdóir k-ópóideach Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    KOP Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    kappa opioid receptor | κ-opioid receptor | kappa receptor | κ receptor | KOP
    en
    Definition "class of opioid receptor [ IATE:1666898 ] mediating analgesia (pain relief), sedation, miosis (constricted pupils) and diuresis" Reference "COM-EN, based on:EMBL-EBI. IPR000452 Kappa opioid receptor http://www.ebi.ac.uk/interpro/DisplayIproEntry?ac=IPR000452 [16.5.2012]"
    Comment Dynorphin is the most potent endogenous ligand.The receptors were named using the first letter of the first ligand that was found to bind to them. Morphine was the first chemical shown to bind to mu receptors.
  4. SOCIAL QUESTIONS|health|pharmaceutical industry
    gabhdóir mu-ópóideach Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    MU-Rezeptor
    de
    mu receptor | μ-receptor | mu-opioid receptor | μ-opioid receptor | MOP
    en
    Definition "class of opioid receptors [ IATE:1666898 ] mediating analgesia (pain relief), hypothermia, respiratory depression , miosis (constricted pupils), bradycardia [ IATE:1499659 ], nausea, euphoria and physical dependence" Reference "COM-EN, based on:EMBL-EBI. IPR000105 Mu opioid receptor http://www.ebi.ac.uk/interpro/IEntry?ac=IPR000105 [16.5.2012]"
    Comment "Beta-endorphin is the most potent endogenous ligand [ IATE:1463918 ].The receptors were named using the first letter of the first ligand that was found to bind to them. Morphine was the first chemical shown to bind to mu receptors. The first letter of the drug morphine is m, but in biochemistry there is a tendency to use Greek letters, thus turning the m to μ."
    récepteur 'mu'
    fr
  5. SOCIAL QUESTIONS|health|pharmaceutical industry
    druga neamh-ópóideach Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    non-opioid drug | non-opoid drug | non-narcotic | non-narcotic analgesic | non-narcotic analgesic drug | non-narcotic agent | non-opioid analgesic drug | non-opioid analgesic | non-opoid
    en
    Definition "analgesic [ IATE:1364708 ] used to alleviate mild or moderate pain and which mediates its effect through receptors other than opioid receptors" Reference "COM-EN based on: Grunenthal > Pain and treatment > Non-opioids http://www.grunenthal.com/grt-web/Grunenthal_Group/Patients/Definition_of_Pain/Pain_Therapy/Non-Opioids/265300360.jsp Oxford Handbook of Palliative Care http://books.google.be/books?id=14S77xH9lSsC&pg=PA229&dq=%22non-opioids+are%22&hl=en&sa=X&ei=woayU4ziOoKxO_GqgIAC&redir_esc=y#v=onepage&q=%22non-opioids%20are%22&f=false [1.7.2014]"
    Comment Examples of non-opioids are aspirin, paracetamol and NSAIDs.
  6. SOCIAL QUESTIONS|health|pharmaceutical industry
    gabhdóir ópóideach Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Rezeptor für Opiate | Opiat-Rezeptor
    de
    opioid receptor | receptors
    en
    Definition "receptor with opioids [ IATE:3529317 ] as ligands" Reference "Wikipedia. Opioid receptor http://en.wikipedia.org/wiki/Opioid_receptor [16.5.2012]"
    Comment There are three principal classes of opioid receptors, μ, κ, δ (mu, kappa, and delta), although up to seventeen have been reported, and include the ε, ι, λ, and ζ (Epsilon, Iota, Lambda and Zeta) receptors.
    récepteur opioïde
    fr
    Definition récepteur cérébral des opiacés Reference Pour la Science,mai 1991
  7. SOCIAL QUESTIONS|social affairs|social problem · SOCIAL QUESTIONS|health|health policy · SOCIAL QUESTIONS|health|medical science
    teiripe ionadaithe le hóipiamóidigh Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    opioidgestützte Substitutionstherapie | opioidgestützte Substitutionsbehandlung
    de
    opioid substitution treatment | opioid substitution therapy | OST | opioid substitution | substitution treatment | substitution therapy
    en
    Definition form of medical care offered to opiate addicts (primarily heroin addicts) based on a similar or identical substance to the drug normally used Reference "European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) > Key role of substitutionin drug treatment, http://www.emcdda.europa.eu/attachements.cfm/att_33470_EN_Dif01en.pdf (24.11.2009)"
    Comment It is offered in two forms: maintenance — providing the user with enough of the substance to reduce risky or harmful behaviour; or detoxification — gradually cutting the quantity of the drug to zero.
    traitement de substitution aux opiacés | TSO
    fr
  8. SOCIAL QUESTIONS|health|pharmaceutical industry
    agónaí k-ópóideach Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    κ-opioid agonist | κ-agonist opioid | kappa-opioid agonist | kappa-opioid receptor agonist | κ-opioid receptor agonist | κ-agonist | kappa-agonist
    en
    Definition "substance that binds to κ-opioid receptors [ IATE:1231575 ] and activates them" Reference "COM-EN, based on:Wikipedia. kappa Opioid receptor http://en.wikipedia.org/wiki/Kappa_Opioid_receptor [5.7.2012]"
  9. SOCIAL QUESTIONS|social affairs|social problem
    teiripe le hagónaithe ópóideacha Reference An Lárionad Faireacháin Eorpach um Dhrugaí agus Andúil i nDrugaí (EMCDDA)
    ga
    Definition agónaithe opóideacha a bhfuil measúnú críochnúil déanta orthu, ag gairmithe creidiúnaithe, faoi chuimsiú cleachtais aitheanta leighis, a thabhairt do dhaoine a bhfuil spleáchas opióideach orthu chun aidhmeanna sainithe cóireála a bhaint amach Reference An Lárionad Faireacháin Eorpach um Dhrugaí agus Andúil i nDrugaí (EMCDDA) (11.2022)
    Comment San Eoraip, is gnách gur rogha cóireála fadtéarmach é OAT, agus is iad Meatadón nó búipreanoirfín na hagónaithe ópóideacha leighis is coitianta a úsáidtear. Tá roinnt aidhmeanna teiripeacha ann don chineál seo cur chuige, lena n-áirítear laghdú nó deireadh a chur le húsáid neamhleighis ópóideach agus le rioscaí gaolmhara, agus chun tacú le staonadh trí chomharthaí aistarraingthe a chosc, chomh maith le handúil drugaí a íoslaghdú.
    Opioid-Agonisten-Therapie | OAT
    de
    Definition Verabreichung gründlich geprüfter Opioid-Agonisten durch zugelassene Fachkräfte im Rahmen einer anerkannten medizinischen Methode an Personen mit einer Opioidabhängigkeit mit dem Ziel, festgelegte Behandlungsziele zu erreichen Reference Europäische Beobachtungsstelle für Drogen und Drogensucht (EMCDDA) (11.2022)
    Comment In Europa wird die OAT in der Regel als Langzeitbehandlungsmethode angewendet. Die häufigsten eingesetzten medizinischen Opioid-Agonisten sind Methadon und Buprenorphin. Der Ansatz beinhaltet eine Reihe therapeutischer Zielsetzungen, darunter die Reduzierung oder Beendigung des nicht medizinischen Konsums von Opioiden sowie der damit verbundenen Risiken und die Unterstützung der Abstinenz durch die Vermeidung von Entzugserscheinungen sowie die Minimierung des Verlangens nach Drogenkonsum.
    opioid agonist therapy | opioid agonist treatment | OAT | opioid agonist pharmacotherapy | OAP
    en
    Definition administration of thoroughly evaluated opioid agonists, by accredited professionals, in the framework of recognised medical practice, to people with opioid dependence for achieving defined treatment aims Reference "World Health Organization, ""Opioid agonist pharmacotherapy used for the treatment of opioid dependence (maintenance)"", https://www.who.int/data/gho/indicator-metadata-registry/imr-details/2718 (8.11.2022)"
    Comment In Europe, OAT is usually a long-term treatment option, and Methadone or buprenorphine are the most common medical opioid agonists used. There are a number of therapeutic aims for this kind of approach, which include reducing or ending non-medical use of opioids and associated risks and supporting abstinence by preventing withdrawal symptoms, as well as minimizing drug craving
    traitement par agonistes opioïdes
    fr
    Definition administration d’agonistes opioïdes ayant fait l’objet d’une évaluation approfondie, par des professionnels agréés, dans le cadre d’une pratique médicale reconnue, à des personnes dépendantes aux opioïdes afin d’atteindre des objectifs de traitement définis Reference Observatoire européen des drogues et des toxicomanies (EMCDDA) (18.11.2022)
    Comment En Europe, le traitement par agonistes opioïdes est généralement une option thérapeutique à long terme, et la méthadone ou la buprénorphine sont les agonistes opioïdes médicaux les plus fréquemment utilisés. Il existe un certain nombre d’objectifs thérapeutiques pour ce type d’approche, dont la réduction ou l’abandon de l’usage non médical des opioïdes et des risques associés et l’aide à l’abstinence en prévenant les symptômes de sevrage, ainsi que la réduction au minimum de l’état de manque.